Patterns and prognostications in immune-related adverse events from immunotherapy treatment

Yevgeniy Semenov, MD, MA, a physician-investigator in the Mass General Department of Dermatology and an Assistant Professor of Dermatology at Harvard Medical School, and Guihong Wan, Ph.D., an Instructor of Dermatology at Massachusetts General Hospital and Harvard Medical School, are the senior author and the first author, respectively, of a new study in The Lancet Oncology. The study is titled “Multi-Organ Immune-Related Adverse Events from Immune Checkpoint Inhibitors and their Downstream Implications: A Retrospective Multicohort Study.” Here, they answer questions about their latest research. What question were you investigating with this study? What are the patterns and prognostic implications of Read More